16 April, 2010
Authors of articles with favorable opinions of Avandia’s safety received money from Glaxo, reports The New York Times.
The New York Times reports that an analysis of Avandia research finds a “slant in articles” on the safety of the diabetes drug:
A new analysis of reviews and articles about the controversial diabetes drug… Continue reading Scientists with positive opinion of Avandia safety were paid by Glaxo, reports New York Times
Category: Avandia Cardiovascular Risk | Avandia News | Avandia Safety23 March, 2010
FDA in Saudi Arabia suspends diabetes drug Avandia
Distribution of Avandia has been suspended for six months by the Saudi Food and Drug Authority (SFDA), linking use of the diabetes drug to adverse cardiovascular effects. A decision has not been made whether a permanent Avandia recall will follow.
“The S FDA Committee… Continue reading Avandia suspended from market by Saudi FDA
Category: Avandia Cardiovascular Risk | Avandia News | Avandia Recall | Avandia Safety | Avandia Side Effects23 March, 2010
Avandia research study shows experts defending the diabetes drug had financial ties to GlaxoSmithKline
They discovered that 94% of the authors who defended Avandia (rosiglitazone) had financial ties to drug makers. Almost half of the financial ties amounted to a conflict of interest… Continue reading Avandia heart attack risk researchers had financial ties to drug maker, conflicts of interest
Category: Avandia Cardiovascular Risk | Avandia News | Avandia Safety | Avandia Side Effects23 February, 2010
The U.S. Food and Drug Administration is reviewing data on possible heart risks with GlaxoSmithKline diabetes drug Avandia but has not reached any new conclusions. The FDA will hold a public meeting in July 2010 to discuss the risks and benefits of the Avandia, but said in the meantime doctors and patients should continue to use Avandia Continue reading FDA: No new conclusions on Glaxo's Avandia yet
Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety